The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Fungasil 250 mg tablets

Clonmel Healthcare LtdPA0126/141/001

Main Information

Trade NameFungasil 250 mg tablets
Active SubstancesTerbinafine
Dosage FormTablet
Licence HolderClonmel Healthcare Ltd
Licence NumberPA0126/141/001

Group Information

ATC CodeD01BA Antifungals for systemic use
D01BA02 terbinafine


License statusAuthorised
Licence Issued12/08/2009
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceNone
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable ListTerbinafine 250 mg Tablets
Interchangeable List CodeIC0150-130-002
Interchangeable List DocumentPDF of Interchangeable List
« Back